Literature DB >> 3789748

Rat brain hexokinase: location of the substrate nucleotide binding site in a structural domain at the C-terminus of the enzyme.

M Nemat-Gorgani, J E Wilson.   

Abstract

8-Azido-ATP serves as a substrate for rat brain hexokinase (ATP:D-hexose 6-phosphotransferase, EC 2.7.1.1). Irradiation of hexokinase in the presence of this photoactivatable ATP analog results in inactivation of the enzyme. ATP and hexose 6-phosphates (Glc-6-P, 1,5-anhydroglucitol-6-P) previously shown to competitively inhibit nucleotide binding protect the enzyme from photoinactivation; other hexose 6-phosphates do not. Hexoses (Glc, Man) previously shown to enhance nucleotide binding also protect against photoinactivation; other hexoses do not. These effects of hexoses and hexose 6-phosphates can be interpreted in terms of the conformational changes previously shown to result from the binding of these ligands and to influence the characteristics of the nucleotide binding site (M. Baijal and J. E. Wilson (1982) Arch. Biochem. Biophys. 218, 513-524). Limited tryptic cleavage of the enzyme produces three major fragments having molecular weights of about 10K, 40K, and 50K, and thought to represent major structural domains within the enzyme (P. G. Polakis and J. E. Wilson (1984) Arch. Biochem. Biophys. 234, 341-352). Tryptic cleavage of the enzyme, photoinactivated in the presence of 14C-labeled azido-ATP, discloses prominent labeling of the 10K and 40K domains, which are known to originate from the N- and C-terminal regions, respectively. Labeling of the 40K domain is influenced by ligands in a manner that corresponds to the effectiveness of these ligands in protecting against photoinactivation whereas labeling of the 10K domain is not affected by these same ligands. It is concluded that the 40K domain includes the binding site for nucleotide substrates. More refined two-dimensional peptide mapping techniques demonstrate that the predominant site of labeling is a peptide segment, molecular weight approximately 20K, that is located in the central and/or C-terminal region of the 40K domain. Labeling of the 10K domain is attributed to nonspecific interaction of azido-ATP with the hydrophobic sequence shown to be located at the N-terminus of brain hexokinase (P. G. Polakis and J. E. Wilson (1985) Arch. Biochem. Biophys. 236, 328-337).

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3789748     DOI: 10.1016/0003-9861(86)90055-x

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  7 in total

1.  Cleavage of hexokinase II to two domains by trypsin without significant change in catalytic activity.

Authors:  H Okazaki; Y Takebayashi; M Ando; S Date; H Tokuda; S Ishibashi
Journal:  Mol Cell Biochem       Date:  1992-11-04       Impact factor: 3.396

2.  Structure of the human hexokinase type I gene and nucleotide sequence of the 5' flanking region.

Authors:  A Ruzzo; F Andreoni; M Magnani
Journal:  Biochem J       Date:  1998-04-15       Impact factor: 3.857

3.  Complete amino acid sequence of rat brain hexokinase, deduced from the cloned cDNA, and proposed structure of a mammalian hexokinase.

Authors:  D A Schwab; J E Wilson
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

4.  A recombinant human 'mini'-hexokinase is catalytically active and regulated by hexose 6-phosphates.

Authors:  M Magnani; M Bianchi; A Casabianca; V Stocchi; A Daniele; F Altruda; M Ferrone; L Silengo
Journal:  Biochem J       Date:  1992-07-01       Impact factor: 3.857

5.  Regulation and cytoprotective role of hexokinase III.

Authors:  Eugene Wyatt; Rongxue Wu; Wael Rabeh; Hee-Won Park; Mohsen Ghanefar; Hossein Ardehali
Journal:  PLoS One       Date:  2010-11-03       Impact factor: 3.240

6.  Enzymatic properties of overexpressed human hexokinase fragments.

Authors:  M Bianchi; G Serafini; E Bartolucci; C Giammarini; M Magnani
Journal:  Mol Cell Biochem       Date:  1998-12       Impact factor: 3.396

7.  Glucose phosphorylation and mitochondrial binding are required for the protective effects of hexokinases I and II.

Authors:  Lin Sun; Shetha Shukair; Tejaswitha Jairaj Naik; Farzad Moazed; Hossein Ardehali
Journal:  Mol Cell Biol       Date:  2007-11-26       Impact factor: 4.272

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.